Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

Overview of attention for article published in BMC Neurology, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 1 news outlet

twitter: 12 X users

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 61 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 32,983 followers.

RT @esclerosiseme: Estudio (https://t.co/WJz1EV8VvY) con pacientes de #EsclerosisMúltiple con modificadores orales señala: aprox. 1/5 no se…

11 Nov 2020

Reply Repost Favourite

RT @esclerosiseme: Estudio (https://t.co/WJz1EV8VvY) con pacientes de #EsclerosisMúltiple con modificadores orales señala: aprox. 1/5 no se…

11 Nov 2020

Reply Repost Favourite

RT @esclerosiseme: Estudio (https://t.co/WJz1EV8VvY) con pacientes de #EsclerosisMúltiple con modificadores orales señala: aprox. 1/5 no se…

10 Nov 2020

Reply Repost Favourite

Estudio (https://t.co/WJz1EV8VvY) con pacientes de #EsclerosisMúltiple con modificadores orales señala: aprox. 1/5 no se adhiere al tratamiento y 1/4 lo interrumpe antes del año ➡ Personas con EM o familiares cuidadores, pueden ayudar con esta encuesta: h

10 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.